A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Ashish, Kakkad
- Sjogren’s Syndrome – A case report
Authors
1 Shri K. K. Sheth Physiotherapy College, Rajkot, Gujarat, IN
Source
Indian Journal of Physiotherapy & Occupational Therapy-An International Journal, Vol 6, No 2 (2012), Pagination: 68-69Abstract
No abstractKeywords
No keywords
References
- Havery M. Black’s medical dictionary, A & C publication limited, London, 41st edition: :647
- Sjogren H. Zur Kenntnis der keratoconjunctivitis sicca. Doctoral thesis, 1933.
- He J, Zhao J, Li Z (2008). “Mucosal administration of alpha-fodrin inhibits experimental Sjögren’s syndrome autoimmunity”. Arthritis Res. Ther. 10 (2): R44. doi:10.1186/ ar2403. PMID 18419828. PMC 2453764. http://arthritisresearch. com/content/10/2/R44
- Golwala A., Medicine for students, 20th edition, :1008
- Franceschini F, Cavazzana I (February 2005). “Anti-Ro/ SSA and La/SSB antibodies”. Autoimmunity 38 (1): 55–63. doi:10.1080/08916930400022954. PMID 15804706.
- V Goëb et al. (2007). “Clinical significance of autoantibodies recognizing Sjogren’s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome”. doi:10.1111/j.1365-2249.2007.03337.x. http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1868868/.
- http://www.wikipedia.org
- Effect of Human Immunodeficiency Virus Infection on Nerve Conduction Velocity Study in Neurologically Asymptomatic Patients
Authors
1 Shri K.K. Sheth Physiotherapy College, Rajkot, Gujarat, IN
Source
Indian Journal of Physiotherapy & Occupational Therapy-An International Journal, Vol 6, No 1 (2012), Pagination: 44-47Abstract
Aims and Objective
1. To study the nerve conduction velocity in Human Immunodeficiency Virus seropositive patients. 2. To analyze whether it is an axonal or a demyelinating neuropathy.
Purpose of Study
One of possible neurological complications with Human Immunodeficiency Virus infection is Peripheral Nervous System affection if patient presented very late. The purpose of study is to assess the effect of Human Immunodeficiency Virus on nerve conduction study even if patient has not symptoms of neuropathy.
Materials & Methodology
The cross-sectional observational study was conducted on 18 Human Immunodeficiency Virus seropositive patients (Mean age=34.3 years) having no clinical features of neuropathy like pain, numbness, parasthesiae, focal weakness as case group and 20 normal healthy individuals (Mean age=34.3 years) as control group in Civil Hospital, Ahmedabad. Subjects exposed to factors affecting nerve conduction velocities e.g. alcohol, drugs (vincristine, isoniazide, antiretroviral therapy, antikoch's therapy), suffering from diabetes, uremia or family history of neuropathy, were not included. Subjects were selected by sample of convenience. Nerve conduction studies were done on left side upper limb and lower limb in lying. The amplitude (peak to peak) and nerve conduction velocities were measured for Median nerve both motor and sensory, Peroneal nerve, Sural nerve using instrument (RMS-EMG-EP-MK-II, Version-1.1), measuretape, thermometer, weighing-machine, height-scale, sketch-pen, spirit, electrode gel, cotton and adhesive-tape.
Results
Statistical analysis was done with student's t-test. t-values for Median motor nerve conduction velocity, Peroneal distal amplitude, Sural distal amplitude were 2.661, 2.324, 2.565 respectively which showed significant difference at 0.05 significance level. t-values for Median motor distal amplitude, Peroneal nerve conduction velocity, Median sensory distal amplitude, Median sensory nerve conduction velocity, Sural nerve conduction nerve conduction velocity are 0.666, 0.988, 0.913, 1.402, 0.827 respectively which showed no significant difference at 5% level.
Conclusion
Results show presence of demyelinating neuropathy in Median motor nerve and axonal neuropathy Peroneal and Sural nerves suggestive of presence of subclinical peripheral nerve involvement in asymptomatic Human Immunodeficiency Virus seropositive patients.
Keywords
Nerve Conduction Study, Human Immunodeficiency Virus, NeuropathyReferences
- Golwala A. F., Golwala S. A. 2003 Medicine For Students, The National Book Depot, Mumbai, Twentieth edition, 932.
- McReynolds CJ, Garske GG: Current issues in HIV disease and AIDS: Implications for health and rehabilitation professionals, Work 17; 2001:117-124
- Misra UK, Kalita J. Clinical Neurophysiology., 2nd ed., Delhi; Reed Elsevier India Pvt. Ltd., 2006:1-32,81,82.
- Cornblath DR, McArthur JC: Predominantly sensory neuropathy associated with acquired immunodeficiency symdrome: prevalence clinical features based on a population-based survey, Arch Neurology; 1998; 45: 945-948.
- Ho HH, Chung C. Liu T et al: A randomized controlled trial on the treatment for acute partial ischeamic stroke with acupuncture, Neuroepidemiogy 1993: 12: 106-113.
- Simpson DM, Olney RK: Peripheral neuropathies associated with human immunodeficiency virus infection. In Dyck PJ, editor: Peripheral neuropathy. Philadelphia. 1994; WB Saunders.
- Griffin JWI, Wesselingh S. Oaklander AL et al: MRNA fingerprinting of cytokines and growth factors: a new means of characteristic nerve biopsies, Neurology 43(2 Suppl): A232, 1993.
- Fuller GN, Jacoba JM, Galloff RJ. Subclinical peripheral nerve involvement in AIDS. An electrophysiological and pathological study. J Neurolosurg Psychiat 1991: 54:118.